Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cell and Gene Therapy Catapult is an independent innovation and technology organization based in the United Kingdom, established to accelerate the growth of the global cell and gene therapy industry. It provides specialized expertise, state-of-the-art manufacturing facilities, and clinical trial support to help companies bridge the gap between early-stage research and commercial availability. By offering a unique collaborative environment, the Catapult enables developers to scale up manufacturing processes and navigate complex regulatory pathways. Its flagship manufacturing center in Stevenage is a global hub for large-scale production of advanced therapy medicinal products (ATMPs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CGT.